secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2026-07-13T21:28:01+00:00
Accession:  0001087294-26-000055
Event type: dividend
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland Pharmaceuticals declares special dividend of $1.50/share, authorizes $5M buyback
--------------------------------------------------------------------------------

- Special cash dividend of $1.50 per share, payable July 31, 2026 to holders of record July 23, 2026.
- Board authorized open-market share repurchase program of up to $5 million, replacing prior $10M program.
- Dividend follows $100M cash received from Apotex strategic transaction; up to $11M additional payments expected.
- Several board members plan to establish new share purchase plans to increase holdings.
- Company retains pipeline of ifetroban for Duchenne, systemic sclerosis, IPF, and cancer metastasis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000108729426000055/0001087294-26-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000108729426000055/cpix-20260713.htm
  HTML page:      https://secwatch.observer/filing/0001087294-26-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer